Chetan Bettegowda

机构：Johns Hopkins University, Johns Hopkins Medicine, Lustgarten Foundation, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore · ORCID：0000-0001-9991-7123

发表论文 740 篇 · 总被引 33649 次 · h-index 70

代表论文

• TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers (2025 · Nature Cancer · 被引 3)
• Ivosidenib and Vorasidenib Decrease Intratumoral 2-Hydroxyglutarate and Total Choline Levels in Patients with Lower-Grade Glioma: An In Vivo MR Spectroscopy Study (2026 · Clinical Cancer Research · 被引 2)
• Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain (2026 · Advanced Science · 被引 1)
• A shared injury–homeostasis gradient in the human CSF proteome across neurological disease (2026 · Research Square)
• Supplementary material1 from Ivosidenib and Vorasidenib Decrease Intratumoral 2-Hydroxyglutarate and Total Choline Levels in Patients with Lower-Grade Glioma: An In Vivo MR Spectroscopy Study (2026)
• Data from Ivosidenib and Vorasidenib Decrease Intratumoral 2-Hydroxyglutarate and Total Choline Levels in Patients with Lower-Grade Glioma: An In Vivo MR Spectroscopy Study (2026)